Results 171 to 180 of about 3,153,921 (233)

The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans.

Journal of Hepatology, 2016
P. Luukkonen, You Zhou, T. Hyötyläinen, M. Leivonen, J. Arola, M. Orho-Melander, M. Orešič, H. Yki-Järvinen   +7 more
semanticscholar   +1 more source

The microcirculation in the first days of ICU admission in critically ill COVID-19 patients is influenced by severity of disease. [PDF]

Sci Rep
Brouwer F, Ince C, Pols J, Uz Z, Hilty MP, Arbous MS.   +5 more
europepmc   +1 more source

Effects of Spirulina platensis supplementation on quality of life, severity of disease and serum total antioxidant capacity, malondialdehyde and zonulin in constipation-predominant irritable bowel syndrome: protocol for a randomised, double-blinded, placebo-controlled clinical trial from Iran. [PDF]

BMJ Open
Jafari Nasab S, Hajihashemi P, Feizi A, Shahoon H, Ani A, Roohafza H, Adibi P, Entezari M, Bagherniya M.   +8 more
europepmc   +1 more source

The effects of opium consumption on severity of disease on hospitalized COVID-19 patients in East of Iran, a prospective cohort study. [PDF]

Transl Clin Pharmacol
Pagheh AS, Kazemi T, Riahi SM, Karimi M, Foogerdi M, Arian A, Heydari S, Ghoddousi MY, Vahdati P, Khazdair MR.   +9 more
europepmc   +1 more source

A Delphi panel to build consensus on assessing disease severity and disease progression in adult patients with hypophosphatasia in the United States. [PDF]

J Endocrinol Invest
Dahir KM, Rush ET, Diaz-Mendoza S, Kishnani PS.   +3 more
europepmc   +1 more source

Emicizumab is well tolerated and effective in people with congenital hemophilia A regardless of age, severity of disease, or inhibitor status: a scoping review. [PDF]

Res Pract Thromb Haemost
Young G, Pipe SW, Kenet G, Oldenburg J, Safavi M, Czirok T, Nissen F, Mahlangu J.   +7 more
europepmc   +1 more source

Low platelet count at diagnosis of anti-neutrophil cytoplasmic antibody-associated vasculitis is correlated with the severity of disease and renal prognosis. [PDF]

Clin Exp Med
Jin Y, Wang F, Tang J, Luo L, Huang L, Zhou F, Qi E, Hu X, Deng S, Ge H, Jiang Y, Feng J, Li X.   +12 more
europepmc   +1 more source

Appraising Drugs Based on Cost-effectiveness and Severity of Disease in Norwegian Drug Coverage Decisions.

JAMA Netw Open, 2022
Tranvåg EJ, Haaland ØA, Robberstad B, Norheim OF.   +3 more
europepmc   +1 more source